AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31971338 — intervention group
Group type: COMPARATOR
Intervention: Angiography-guided stenting
Number of subjects: 100
Study 29233857 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating late
Number of subjects: 10
Study 29233857 — intervention group
Group type: COMPARATOR
Intervention: Eating early
Number of subjects: 10
Study 27354084 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Traveller intervention (10-min sessions, 3 days per week for 6 weeks)
Number of subjects: 10
Study 27354084 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 10
Study 24385115 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin/tretinoin gel patches
Number of subjects: 95
Study 24385115 — intervention group
Group type: COMPARATOR
Intervention: Vehicle gel patches
Number of subjects: 95
Study 24385115 — intervention group
Group type: COMPARATOR
Intervention: Blank patches (no gel)
Number of subjects: 95
Study 22428144 — intervention group
Group type: EXPERIMENTAL
Intervention: Lutein diacetate (20 mg/day)
Number of subjects: 30
Study 22428144 — intervention group
Group type: EXPERIMENTAL
Intervention: Crystalline lutein (20 mg/day)
Number of subjects: 30
Study 22428144 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 20828487 — intervention group
Group type: EXPERIMENTAL
Intervention: Iso-strain work situation (high demands, low control, and low social support) among females
Number of subjects: 532
Study 20828487 — intervention group
Group type: EXPERIMENTAL
Intervention: Strained work situation (high demands, low control)
Number of subjects: 532
Study 20828487 — intervention group
Group type: EXPERIMENTAL
Intervention: Low social support combined with a passive work situation
Number of subjects: 532
Study 20828487 — intervention group
Group type: COMPARATOR
Intervention: Iso-strain model
Number of subjects: 532
Study 18430173 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (Restylane, 1.4 mL)
Number of subjects: 10
Study 18430173 — intervention group
Group type: COMPARATOR
Intervention: Collagen (Cosmoplast, 2.0 cm³)
Number of subjects: 10
Study 18430173 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid
Number of subjects: 10
Study 18430173 — intervention group
Group type: COMPARATOR
Intervention: Collagen
Number of subjects: 10
Study 15888157 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fluence laser treatment
Number of subjects: 88
Study 15888157 — intervention group
Group type: COMPARATOR
Intervention: Low-fluence laser treatment (Control)
Number of subjects: 88
Study 12552211 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal bupivacaine (ITB) 37.5 mg
Number of subjects: 38
Study 12552211 — intervention group
Group type: COMPARATOR
Intervention: Control (sham spinal)
Number of subjects: 38
Study 10532441 — intervention group
Group type: EXPERIMENTAL
Intervention: Verteporfin (6 mg per square meter of body surface area) administered via intravenous infusion of 30 mL over 10 minutes.
Number of subjects: 609
Study 10532441 — intervention group
Group type: COMPARATOR
Intervention: Placebo (5% dextrose in water) administered via intravenous infusion of 30 mL over 10 minutes.
Number of subjects: 609
Study 10532441 — intervention group
Group type: EXPERIMENTAL
Intervention: Verteporfin therapy for predominantly classic CNV lesions (area of classic CNV occupied 50% or more of the area of the entire lesion).
Number of subjects: 609
Study 10532441 — intervention group
Group type: EXPERIMENTAL
Intervention: Verteporfin treatment.
Number of subjects: 609
Study 10532441 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment.
Number of subjects: 609
Study 8828529 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral corticosteroids (prednisone, median daily dose 20 mg, median duration 2 years)
Number of subjects: 33
Study 8828529 — intervention group
Group type: COMPARATOR
Intervention: Control group (66 patients with asthma)
Number of subjects: 33
Study 1795470 — intervention group
Group type: EXPERIMENTAL
Intervention: roxicam
Number of subjects: 51
Study 1795470 — intervention group
Group type: COMPARATOR
Intervention: aspirin
Number of subjects: 51
Study 1795470 — intervention group
Group type: COMPARATOR
Intervention: basic therapies (nitrates + cardiac glycosides + diuretics)
Number of subjects: 51
Study 7031204 — intervention group
Group type: EXPERIMENTAL
Intervention: Dispersalloy (D)
Number of subjects: 435
Study 7031204 — intervention group
Group type: EXPERIMENTAL
Intervention: Indiloy (I)
Number of subjects: 435
Study 7031204 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental high copper amalgam (E)
Number of subjects: 435
Study 7031204 — intervention group
Group type: EXPERIMENTAL
Intervention: Tytin (T)
Number of subjects: 435
Study 7031204 — intervention group
Group type: COMPARATOR
Intervention: New True Dentalloy (N)
Number of subjects: 435
Study 7031204 — intervention group
Group type: EXPERIMENTAL
Intervention: Aristaloy CR (A)
Number of subjects: 435
Study 30368662 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluma Bond Universal (GU) in self-etch mode
Number of subjects: 42
Study 30368662 — intervention group
Group type: EXPERIMENTAL
Intervention: Single Bond Universal (SU) in self-etch mode
Number of subjects: 42
Study 30368662 — intervention group
Group type: EXPERIMENTAL
Intervention: Prime&Bond Elect Universal (PU) in self-etch mode
Number of subjects: 42
Study 30368662 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil Universal (CU) in self-etch mode
Number of subjects: 42
Study 30368662 — intervention group
Group type: EXPERIMENTAL
Intervention: All Bond Universal (AU) in self-etch mode
Number of subjects: 42
Study 30368662 — intervention group
Group type: COMPARATOR
Intervention: etch-and-rinse mode (all adhesives)
Number of subjects: 42
Study 29145309 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigid taping (RT)
Number of subjects: 24
Study 29145309 — intervention group
Group type: COMPARATOR
Intervention: Non-taping (NT)
Number of subjects: 24
Study 26474055 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led, telephone-based follow-up
Number of subjects: 537
Study 26474055 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 537
Study 25063274 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular glucagon
Number of subjects: 0
Study 25063274 — intervention group
Group type: COMPARATOR
Intervention: Hyperinsulinaemic hypoglycaemia testing
Number of subjects: 0
Study 25063274 — intervention group
Group type: COMPARATOR
Intervention: Hyperinsulinaemic-euglycaemic conditions
Number of subjects: 0
Study 25063274 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucagon treatment in isolated rat pancreatic islets
Number of subjects: 0
Study 25063274 — intervention group
Group type: COMPARATOR
Intervention: Diazoxide exposure in pancreatic islets
Number of subjects: 0
Study 25063274 — intervention group
Group type: COMPARATOR
Intervention: Anti-insulin antibody exposure in pancreatic islets
Number of subjects: 0
Study 25063274 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucagon treatment in islets pretreated with diazoxide or anti-insulin antibody
Number of subjects: 0
Study 17761454 — intervention group
Group type: EXPERIMENTAL
Intervention: Videotape-assisted questionnaire (VQ)
Number of subjects: 108
Study 17761454 — intervention group
Group type: COMPARATOR
Intervention: Standard questionnaire (SQ)
Number of subjects: 108
Study 14725866 — intervention group
Group type: EXPERIMENTAL
Intervention: Smokers with panic disorder (PD)
Number of subjects: 0
Study 14725866 — intervention group
Group type: COMPARATOR
Intervention: Nonsmokers with panic disorder (PD)
Number of subjects: 0
Study 14725866 — intervention group
Group type: COMPARATOR
Intervention: Smokers without panic disorder (PD)
Number of subjects: 0
Study 14725866 — intervention group
Group type: COMPARATOR
Intervention: Nonsmokers without panic disorder (PD)
Number of subjects: 0
Study 11401111 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 297
Study 11401111 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 297
Study 9334525 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 20
Study 9334525 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 8231773 — intervention group
Group type: EXPERIMENTAL
Intervention: Leg cycle ergometry
Number of subjects: 26
Study 8231773 — intervention group
Group type: COMPARATOR
Intervention: Weight training
Number of subjects: 26
Study 2446132 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate adjuvant cisplatin‐based chemotherapy
Number of subjects: 195
Study 2446132 — intervention group
Group type: COMPARATOR
Intervention: Observation with treatment at relapse
Number of subjects: 195
Study 11315838 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin lispro
Number of subjects: 21
Study 11315838 — intervention group
Group type: COMPARATOR
Intervention: Regular insulin
Number of subjects: 21
Study 11315838 — intervention group
Group type: EXPERIMENTAL
Intervention: Postprandial MG and 3‐DG
Number of subjects: 21
Study 11315838 — intervention group
Group type: EXPERIMENTAL
Intervention: Postprandial D‐lactate
Number of subjects: 21
Study 29398169 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory muscle training program adjusted to 50% of maximal inspiratory pressure, in addition to standard care.
Number of subjects: 126
Study 29398169 — intervention group
Group type: COMPARATOR
Intervention: Standard care of respiratory physiotherapy (Control group).
Number of subjects: 126
Study 29398169 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory muscle training program.
Number of subjects: 126
Study 29398169 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (experimental and control).
Number of subjects: 126
Study 29960605 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored activity counselling intervention (IG) encouraging to increase daily step count by 5%
Number of subjects: 65
Study 29960605 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 65
Study 29960605 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (IG and CG)
Number of subjects: 65
Study 26822326 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive glycemic control for a mean of 3.7 years
Number of subjects: 8601
Study 26822326 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive glycemic control during active phase
Number of subjects: 8601
Study 26822326 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive glycemic control during prolonged follow-up
Number of subjects: 8601
Study 25009220 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise (RE) - single, unilateral bout using knee extensors (four sets of 10 repetitions at 75% of one repetition maximum on leg press and leg extension)
Number of subjects: 18
Study 25009220 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise (RE)
Number of subjects: 18
Study 22367658 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine (50 mg/d for 7 days)
Number of subjects: 12
Study 22367658 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine (20 mg/d for 7 days)
Number of subjects: 12
Study 22367658 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (50 mg/d for 7 days)
Number of subjects: 12
Study 19946887 — intervention group
Group type: EXPERIMENTAL
Intervention: Zomba Cash Transfer Program (CCT) providing US$10/month and payment of secondary school fees
Number of subjects: 0
Study 19946887 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 17096672 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg
Number of subjects: 284
Study 17096672 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 284
Study 15608524 — intervention group
Group type: EXPERIMENTAL
Intervention: lopinavir/ritonavir (LPV/rtv) 400/100 mg BID plus nevirapine (NVP) 200 mg BID (NVP group, n = 16)
Number of subjects: 31
Study 15608524 — intervention group
Group type: COMPARATOR
Intervention: lopinavir/ritonavir (LPV/rtv) plus the 2 previous NRTIs (NRTI group, n = 15)
Number of subjects: 31
Study 15608524 — intervention group
Group type: EXPERIMENTAL
Intervention: NVP group
Number of subjects: 31
Study 15608524 — intervention group
Group type: COMPARATOR
Intervention: NRTI group
Number of subjects: 31
Study 11857093 — intervention group
Group type: EXPERIMENTAL
Intervention: E2 and Prog replacement
Number of subjects: 20
Study 11857093 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study 10100042 — intervention group
Group type: EXPERIMENTAL
Intervention: Essential oil mouthrinse (Listerine Antiseptic)
Number of subjects: 23
Study 10100042 — intervention group
Group type: EXPERIMENTAL
Intervention: Amine fluoride/stannous fluoride mouthrinse (Meridol)
Number of subjects: 23
Study 10100042 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine mouthrinse (Chlorhexamed‐Fluid)
Number of subjects: 23
Study 7752332 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral ligation of the right spermatic vein
Number of subjects: 65
Study 7752332 — intervention group
Group type: COMPARATOR
Intervention: Bilateral ligation of the spermatic veins
Number of subjects: 65
Study 2401128 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast infusion of felodipine (plasma concentration of 6 ng/ml after 20 minutes, sustained for 8 hours)
Number of subjects: 8
Study 2401128 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow infusion of felodipine (plasma concentration of 6 ng/ml after 8 hours)
Number of subjects: 8
Study 2401128 — intervention group
Group type: COMPARATOR
Intervention: Control infusions with saline and vehicle
Number of subjects: 8
Study 399250 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefaclor (3 x 500 mg)
Number of subjects: 110
Study 399250 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin (3 x 750 mg)
Number of subjects: 110
Study 31393158 — intervention group
Group type: EXPERIMENTAL
Intervention: Judgments of soldiers' actions influenced by the justness of their causes
Number of subjects: 0
Study 31393158 — intervention group
Group type: EXPERIMENTAL
Intervention: Implicit presumption that soldiers identify with their cause
Number of subjects: 0
Study 31393158 — intervention group
Group type: EXPERIMENTAL
Intervention: Alignment with the just side of a war
Number of subjects: 0
Study 31272212 — intervention group
Group type: COMPARATOR
Intervention: Fortified rice with 0 gm lime per 500 gm of rice
Number of subjects: 400
Study 31272212 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified rice with 2.5 gm lime per 500 gm of rice
Number of subjects: 400
Study 31272212 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified rice with 5 gm lime per 500 gm of rice
Number of subjects: 400
Study 31272212 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified rice with 7.5 gm lime per 500 gm of rice
Number of subjects: 400
Study 31272212 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified rice with 10 gm lime per 500 gm of rice
Number of subjects: 400
Study 28836984 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (received 4 weeks training on adolescent sexuality topics)
Number of subjects: 145
Study 28836984 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 145
Study 28836984 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 145
Study 28836984 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 145
Study 26395834 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-P13 (5 mg/kg)
Number of subjects: 213
Study 26395834 — intervention group
Group type: COMPARATOR
Intervention: EU-RMP (5 mg/kg)
Number of subjects: 213
Study 26395834 — intervention group
Group type: COMPARATOR
Intervention: US-RMP (5 mg/kg)
Number of subjects: 213
Study 23356839 — intervention group
Group type: EXPERIMENTAL
Intervention: PhysioDirect
Number of subjects: 2249
Study 23356839 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2249
Study 21629997 — intervention group
Group type: COMPARATOR
Intervention: Acute nicotine (2 mg gum) in non-smokers
Number of subjects: 48
Study 21629997 — intervention group
Group type: COMPARATOR
Intervention: Chronic nicotine use in temporarily abstaining smokers
Number of subjects: 48
Study 19568199 — intervention group
Group type: EXPERIMENTAL
Intervention: Before‐Meals exercise (2 hours of treadmill exercise at 43% of maximal effort)
Number of subjects: 9
Study 19568199 — intervention group
Group type: COMPARATOR
Intervention: After‐Meals exercise (2 hours of treadmill exercise at 43% of maximal effort)
Number of subjects: 9
Study 17584560 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan
Number of subjects: 1357
Study 17584560 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 1357
Study 17584560 — intervention group
Group type: COMPARATOR
Intervention: Telmisartan vs Placebo
Number of subjects: 1357
Study 17584560 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Telmisartan and Ramipril
Number of subjects: 1357
Study 15035520 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactically guided core biopsy (SCB)
Number of subjects: 2403
Study 15035520 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided core biopsy (USCB)
Number of subjects: 2403
Study 15035520 — intervention group
Group type: EXPERIMENTAL
Intervention: Core biopsy (CB)
Number of subjects: 2403
Study 15035520 — intervention group
Group type: EXPERIMENTAL
Intervention: Core biopsy (CB) for masses
Number of subjects: 2403
Study 15035520 — intervention group
Group type: EXPERIMENTAL
Intervention: Core biopsy (CB) for calcifications
Number of subjects: 2403
Study 15035520 — intervention group
Group type: EXPERIMENTAL
Intervention: Core biopsy (CB) for DCIS
Number of subjects: 2403
Study 15035520 — intervention group
Group type: EXPERIMENTAL
Intervention: Core biopsy (CB) for invasive cancer
Number of subjects: 2403
Study 11160540 — intervention group
Group type: EXPERIMENTAL
Intervention: Solid fat rich in lauric acid (Sat-diet)
Number of subjects: 32
Study 11160540 — intervention group
Group type: COMPARATOR
Intervention: Solid fat rich in trans-fatty acids (trans-diet)
Number of subjects: 32
Study 9734742 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene (50 mg/d)
Number of subjects: 259
Study 7853324 — intervention group
Group type: COMPARATOR
Intervention: Standard cuff (23 x 12 cm)
Number of subjects: 50
Study 7853324 — intervention group
Group type: EXPERIMENTAL
Intervention: Large cuff (34 x 15 cm)
Number of subjects: 50
Study 3058132 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone (100-200 mg/d)
Number of subjects: 54
Study 3058132 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium canrenoate (50-200 mg/d)
Number of subjects: 54
Study 3058132 — intervention group
Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 54
Study 31854119 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-octyl cyanoacrylate (OCA)
Number of subjects: 70
Study 31854119 — intervention group
Group type: COMPARATOR
Intervention: Sutures
Number of subjects: 70
Study 30342298 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemafibrate (0.2 mg twice daily)
Number of subjects: 10000
Study 30342298 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 10000
Study 28179438 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemonitoring programme
Number of subjects: 100
Study 28179438 — intervention group
Group type: COMPARATOR
Intervention: Standard management
Number of subjects: 100
Study 26230869 — intervention group
Group type: EXPERIMENTAL
Intervention: External-focus feedback
Number of subjects: 28
Study 26230869 — intervention group
Group type: COMPARATOR
Intervention: Internal-focus feedback
Number of subjects: 28
Study 23978276 — intervention group
Group type: EXPERIMENTAL
Intervention: Barber-assisted intervention with referrals to hypertension specialists
Number of subjects: 138
Study 23978276 — intervention group
Group type: EXPERIMENTAL
Intervention: Barber-assisted intervention with referrals to primary care providers (PCPs)
Number of subjects: 138
Study 23978276 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (pamphlet only)
Number of subjects: 138
Study 21789744 — intervention group
Group type: EXPERIMENTAL
Intervention: WAVCNS index
Number of subjects: 24
Study 18213545 — intervention group
Group type: EXPERIMENTAL
Intervention: Quercetin (1000 mg/day for 3 weeks before, during, and 2 weeks after the race)
Number of subjects: 63
Study 18213545 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 16363014 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 62
Study 16363014 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 62
Study 12743146 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg daily)
Number of subjects: 163
Study 12743146 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 163
Study 10985706 — intervention group
Group type: EXPERIMENTAL
Intervention: Early revascularization
Number of subjects: 1190
Study 10985706 — intervention group
Group type: COMPARATOR
Intervention: Thrombolytic therapy and/or intra-aortic balloon counter-pulsation, coronary angiography, angioplasty and/or coronary artery bypass surgery
Number of subjects: 1190
Study 10985706 — intervention group
Group type: COMPARATOR
Intervention: Ventricular septal rupture
Number of subjects: 1190
Study 10985706 — intervention group
Group type: COMPARATOR
Intervention: Registry patients managed with various treatments
Number of subjects: 1190
Study 9173382 — intervention group
Group type: EXPERIMENTAL
Intervention: Coumarin
Number of subjects: 296
Study 9173382 — intervention group
Group type: EXPERIMENTAL
Intervention: Coumarin plus low-dose acetylsalicylic acid (125 mg/day)
Number of subjects: 296
Study 8255126 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyrone 1 g
Number of subjects: 129
Study 8255126 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyrone 2 g
Number of subjects: 129
Study 8255126 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac sodium 75 mg
Number of subjects: 129
Study 3993547 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (nonselective beta-blocker)
Number of subjects: 25
Study 3993547 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (cardioselective beta-blocker)
Number of subjects: 25
Study 3993547 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 31595300 — intervention group
Group type: EXPERIMENTAL
Intervention: PA-only intervention
Number of subjects: 208
Study 31595300 — intervention group
Group type: EXPERIMENTAL
Intervention: PA+FSM intervention
Number of subjects: 208